Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Sepsis or deep destructive infection
Shock, rapidly progressive pain, bullae, skin anaesthesia, crepitus or pain out of proportion suggests sepsis or necrotising infection rather than routine cellulitis.
Action: Use ABCDE, mark the affected area, obtain urgent blood tests and cultures without delaying intravenous therapy, involve surgery immediately and escalate to critical care when physiology is unstable.
Synopsis
Recognise non-purulent bacterial skin infection, grade severity, distinguish common mimics and prescribe safe narrow therapy while addressing portals of entry and recurrence.
Cellulitis is a spreading infection of dermis and subcutaneous tissue; erysipelas is more superficial, raised and sharply demarcated.
Typical findings are unilateral warmth, erythema, tenderness and swelling, sometimes with lymphangitis or systemic upset.
Bilateral red legs are rarely bilateral cellulitis; venous stasis, lipodermatosclerosis and oedema are common mimics.
Key red flags
Pain out of proportion or rapidly advancing oedema suggests necrotising soft-tissue infection.
Systemic severity
Fever, rigors, tachycardia, hypotension, delirium or reduced urine output indicates systemic involvement and possible sepsis.
Investigation priorities
01
Clinical examination and marked marginFirst step
Define extent, severity, portal of entry and a reproducible baseline for reassessment.
Management branches
STABLEUse narrow oral treatment
Uncomplicated cellulitis is likely, physiology is stable and oral absorption and follow-up are reliable.
Document the site, margin, pain, observations, portal of entry, allergy reaction, renal function and factors that alter organism risk.
Give flucloxacillin 500 mg to 1 g orally four times daily for five to seven days when suitable, using a guideline-listed allergy alternative when needed.
Key medicines
FlucloxacillinGive 500 mg to 1 g orally four times daily for five to seven days for uncomplicated adult cellulitis; use intravenous dosing when severity requires admission.
ClarithromycinGive 500 mg orally twice daily for five to seven days when penicillin allergy makes flucloxacillin unsuitable.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.